FDA Panel Votes on Pimavanserin for Alzheimer Disease Psychosis
Although not bound by the committee’s recommendations, the Agency does take them into consideration when making decisions on approval.
Alzheimer Disease and Dementia
Crenezumab Misses Endpoints in Autosomal-Dominant Alzheimer Disease Trial
Crenezumab is an investigational monoclonal antibody designed to neutralize neurotoxic oligomers, a form of beta-amyloid.
Dementia Risk in Patients With Atrial Fibrillation Tied to Diabetes, Stroke
Researchers sought to assess the risk factors for dementia in older adults with atrial fibrillation.
Impact of Physical Activity on Risk for Disabling Dementia by Gender
In a large, prospective cohort study, researchers assessed the association between daily total physical activity and the risk of developing disabling dementia in the general Japanese population.
Childhood Trauma Tied to Dementia Symptoms in Former Football Players
Researchers sought to determine whether concussions and a history of playing football influenced a possible association between ACEs and poor neuropsychiatric health.
Immunotherapeutic Vaccine Candidate Fast Tracked for Alzheimer Disease
UB-311 is an immunotherapeutic vaccine candidate that targets toxic forms of aggregated amyloid beta in the brain.
Novel Plasma Biomarkers May Improve Prediction of Alzheimer Disease
Researchers established the Florida Consortium for African American Alzheimer’s Disease Studies to identify genetic risk factors and novel plasma biomarkers for AD.
Subcutaneous Anti-Amyloid Beta Antibody Fast Tracked for Alzheimer Disease
In preclinical studies, PRX012 has been shown to bind to beta amyloid plaques and oligomers with high affinity.
Caffeine Intake and Dementia: Can Lewy Bodies Explain the Link?
Researchers sought to investigate the associations between habitual caffeine intake, incident cognitive impairment, and neuropathology.
Mortality Rates Rose During COVID-19 Among Medicare Beneficiaries With Dementia
In a cross-sectional study, researchers compared COVID-19 infection and mortality rates from 2019 and 2020 among Medicare enrollees with Alzheimer disease and related dementias.
- Loading...
Loading...
Next post in Neurology
Loading... 
Loading...